Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T Lymphocyte Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00036790
What this trial is testing

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more
University of Wisconsin, Madison
Large-scale testing (Phase 3)Study completedNCT02770495
What this trial is testing

Postoperative REcurrence and DynamICs of T Cell Subsets in Crohn's Disease

Who this might be right for
Crohn Disease
Hospices Civils de Lyon 59
Early research (Phase 1)Study completedNCT00590083
What this trial is testing

Administration of Virus-Specific Cytotoxic T-Lymphocytes

Who this might be right for
Adenovirus Infection
Baylor College of Medicine 14
Testing effectiveness (Phase 2)Ended earlyNCT01518153
What this trial is testing

Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT)

Who this might be right for
LeukemiaLymphomaMyeloma+1 more
M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)Looking for participantsNCT03190941
What this trial is testing

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

Who this might be right for
Pancreatic CancerGastric CancerGastrointestinal Cancer+2 more
National Cancer Institute (NCI) 110
Early research (Phase 1)Study completedNCT02057445
What this trial is testing

3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma

Who this might be right for
Non-Hodgkins LymphomaHodgkins LymphomaLymphoproliferative Disorder
New York Medical College 1
Large-scale testing (Phase 3)Study completedNCT00265837
What this trial is testing

Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+3 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 72
Not applicableEnded earlyNCT00952185
What this trial is testing

Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more
City of Hope Medical Center 9
Early research (Phase 1)Looking for participantsNCT04099797
What this trial is testing

C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)

Who this might be right for
Diffuse Intrinsic Pontine GliomaHigh Grade GliomaEmbryonal Tumor+1 more
Baylor College of Medicine 56
Early research (Phase 1)Study completedNCT00002980
What this trial is testing

Decitabine in Treating Patients With Melanoma or Other Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
California Cancer Consortium
Early research (Phase 1)Active Not RecruitingNCT02663297
What this trial is testing

Administration of T Lymphocytes for Prevention of Relapse of Lymphomas

Who this might be right for
Hodgkin DiseaseLymphomaLymphoma, Non-Hodgkin+6 more
UNC Lineberger Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT00683046
What this trial is testing

T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies

Who this might be right for
Acute Myelogenous LeukemiaLymphoid LeukemiaChronic Myelogenous Leukemia+6 more
University of Chicago 204
Testing effectiveness (Phase 2)Ended earlyNCT00360776
What this trial is testing

Tipifarnib in Treating Patients With Anemia or Neutropenia and Large Granular Lymphocyte Leukemia

Who this might be right for
Stage III Chronic Lymphocytic LeukemiaStage IV Chronic Lymphocytic LeukemiaT-cell Large Granular Lymphocyte Leukemia
National Cancer Institute (NCI) 25
Not applicableStudy completedNCT00001131
What this trial is testing

Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Testing effectiveness (Phase 2)Study completedNCT01659151
What this trial is testing

Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
H. Lee Moffitt Cancer Center and Research Institute 17
Post-approval studies (Phase 4)UnknownNCT00963222
What this trial is testing

The Study of the Effects of Vitamin A on Immune System in Patients With Atherosclerosis

Who this might be right for
Atherosclerosis
Tehran University of Medical Sciences 60
Not applicableStudy completedNCT00034437
What this trial is testing

Immune Response to Cytomegalovirus

Who this might be right for
Cytomegalovirus Infections
National Heart, Lung, and Blood Institute (NHLBI) 20
Not applicableUnknownNCT04320667
What this trial is testing

Urinary T Cell Biomarker for Prediction in ANCA Glomerulonephritis

Who this might be right for
Glomerulonephritis Acute
Charite University, Berlin, Germany 79
Not applicableUnknownNCT04286477
What this trial is testing

The Immune System in End Stage CKD Patients - Comparison Among Different Modalities of RRT

Who this might be right for
End Stage Renal Disease on Dialysis
University of Ioannina 45
Testing effectiveness (Phase 2)Study completedNCT01967823
What this trial is testing

T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer

Who this might be right for
MelanomaMeningiomaBreast Cancer+2 more
National Cancer Institute (NCI) 11
Next Page